Gemeinsamer BundesausschussBerlinTED
Kaltplasma
Die Erprobung soll der Beantwortung der Frage dienen, ob bei Patientinnen und Patienten mit chronischen Wunden die Kaltplasmabehandlung in Erweiterung zur Standard-Wundbehandlung im Vergleich zur alleinigen Standard-Wundbehandlung hinsichtlich des Endpunkts Wundheilungserfolg überlegen ist.
Clinical Trials
No credit card · Instant access
Content at a glance
- Tender type:
- Tender
- Contracting authority:
- Gemeinsamer Bundesausschuss
- Published:
- July 23, 2026
- Deadline:
- Not specified
- Topic:
- Clinical Trials
Tender description
Die Erprobung soll der Beantwortung der Frage dienen, ob bei Patientinnen und Patienten mit chronischen Wunden die Kaltplasmabehandlung in Erweiterung zur Standard-Wundbehandlung im Vergleich zur alleinigen Standard-Wundbehandlung hinsichtlich des Endpunkts Wundheilungserfolg überlegen ist.
Further details
With free access, documents, deadlines and submission notes are available in a structured format.
- Core requirements of the tender prioritized and prepared
- Deadlines, eligibility criteria and documents in one workflow
- Guidance for structured bid preparation
- Automatically discover matching follow-up tenders
30 days free · no credit card · cancel anytime
All procurement details
Buyer, lots, participants, locations, documents, and procedure data have already been captured. Open any area to see the complete information in your workspace.
6 data areas available
30 days free · no credit card · cancel anytime
Documents
Unlock50 details capturedDocuments · Document bundle
Buyer
Unlock6 details capturedBuyer · Address · Contact
Lots
Unlock1 detail capturedLots LOT-0001
Procedure data
Unlock6 details capturedPublication number · Procedure reference · Buyer reference · Procedure type · +2 more
Bidders and contractors
Unlock3 details capturedBidders and contractors · Address · Contact
Publisher
Unlock6 details capturedPublisher · Address · Contact
Related tenders
4Erprobung von 32P-markierten Mikropartikeln bei lokal fortgeschrittenem Pankreastumor
Gemeinsamer Bundesausschuss (G-BA) BerlinBerlinKlinische Erprobung bei nicht metastasiertem, irresektablem, lokal fortgeschrittenem Pankreastumor: Vergleich einer einmaligen endoskopisch-intratumoralen Injektion von 32P-markierten Mikropartikeln plus Erstlinienchemotherapie vs. alleiniger Chemotherapie hinsichtlich Therapieversagens.Präklinische Vertragsforschung für ein neuartiges endovaskuläres Medizinprodukt
University of Galway (ID 1400)GalwayConducting pre-clinical contract research for the evaluation of a novel endovascular medical device in a large animal model.MRT-Studie zur Untersuchung von Hirnvolumen bei Patienten mit kognitiven Beeinträchtigungen oder leichter Alzheimer-Demenz
PRInnovation GmbHLeipzigPRImus-AD is a Phase II clinical trial investigating the efficacy and safety of an innovative drug in patients with mild cognitive impairment or mild Alzheimer's dementia. The study is randomised, double-blind, and placebo-controlled with three parallel study arms (two verum arms and one placebo arm). The aim of the clinical trial is to examine the effects of the active ingredient on neurotoxic protein structures and to evaluate the potential influence on disease progression. Randomised patients were treated for a minimum of 48 weeks up to 96 weeks. A total of 304 patients were divided into the three different treatment arms. An important read-out of the study is the analysis of magnetic resonance imaging (MRI) data to record changes in brain volume at both the individual and group levels. All MRI scans are generated using the same imaging protocol, T2* gradient echo, and diffusion weighted sequences. The study will be conducted in accordance with international standards for good clinical practice (ICH-GCP) and strict quality management guidelines. The schedule provides for a step-by-step evaluation, including the transfer and backup of image data, analysis, and final dataGALW/COSE1847/26 Conducting technical and pre-clinical research and development of a novel cardiovascular medical device.
University of Galway (ID 1400)GalwayDeadline: Aug 25The University of Galway are developing a novel technology for supporting the right ventricle during periods of pressure overload. The team are seeking tenders for two different lots of services: Lot 1: R and D Consultant to provide services in the development of a novel cardiovascular medical device for evaluation in a pre-clinical study. Lot 2: The tenderer will offer services for the evaluation of a novel cardiovascular medical device in a large animal model. This contract will involve the development of a protocol and study strategy. The study will include implanting prototype devices in acute animals to demonstrate proof of concept, as well as implanting animals for acute evaluation to support assessment of the prototypes.
Frequently asked questions about this tender
- How can I apply for this tender?
- Create a free account on Auftrag One. You will then see all documents, deadlines and submission notes in a structured workflow.
- What is the submission deadline?
- No specific submission deadline is currently stated for this notice.
- Who is the contracting authority?
- The contracting authority is Gemeinsamer Bundesausschuss.
- Which documents are needed to get started?
- Typically you need the service description, proof of eligibility, deadline notes and possibly form sheets. On Auftrag One these items are displayed in prioritized order.